https://clinicaltrials.gov/ct2/show/NCT02963506?type=Intr&cond=ankylosing+spondylitis&phase=0124&lupd_s=07%2F03%2F2020&lupd_d=14&sort=nwst
STUDY TITLE:
A Study to Evaluate the Efficacy and Safety of Different Doses of Bimekizumab in Subjects With Active Ankylosing Spondylitis
DESCRIPTION:
Condition: Ankylosing Spondylitis
Interventions: Other: Placebo; Drug: Bimekizumab
Sponsor: UCB Biopharma S.P.R.L.
Completed
CLINICALTRIALS.GOV IDENTIFIER:
NCT02963506
FIRST POSTED:
Tue, 15 Nov 2016 12:00:00 EST
LAST UPDATE POSTED:
07/17/20 06:50AM
STUDY LINK / URL:
https://clinicaltrials.gov/ct2/show/NCT02963506?type=Intr&cond=ankylosing+spondylitis&phase=0124&lupd_s=07%2F03%2F2020&lupd_d=14&sort=nwst